Efficacy of BCNU and paclitaxel loaded subcutaneous implants in the interstitial chemotherapy of U-87 MG human glioblastoma xenografts

International Journal of Pharmaceutics

Volumn 238, Issue 1-2, 2002, Pages 111-121

  Vogelhuber, W ^a   Spruss T ^a   Bernhardt, G ^a   Buschauer, A ^a   Gopferich A ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

BCNU; Biodegradable polymer; Local therapy; Malignant brain tumor; Paclitaxel; Polyanhydride

Indexed keywords

1,3 BIS(CARBOXYPHENOXYPROPANE) SEBACIC ACID COPOLYMER; ANTINEOPLASTIC AGENT; CARMUSTINE; CYTOSTATIC AGENT; PACLITAXEL; POLYGLACTIN; POLYMER; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; BIODEGRADABLE IMPLANT; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER MODEL; CANCER REGRESSION; CHEMOSENSITIVITY; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG RELEASE; GLIOBLASTOMA; HUMAN; HUMAN CELL; INOCULATION; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BRAIN NEOPLASMS; CARMUSTINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG IMPLANTS; EXCIPIENTS; GLIOBLASTOMA; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PACLITAXEL; POLYMERS;

EID: 0037093702     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(02)00061-3     Document Type: Article

References (40)

1. Ionizing radiation improves survival in mice bearing intracranial high-grade gliomas injected with genetically modified herpes simplex virus
2. Polymers to treat brain tumours
3. Biodegradable polymer implants to treat brain tumors
4. Interstitial chemotherapy with drug polymer implants for the treatment of recurrent gliomas
5. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymer-brain Tumor Treatment Group
6. Cytotoxicity of taxol in vitro against human and rat malignant brain tumors
7. Salvage chemotherapy with paclitaxel for recurrent primary brain tumors
8. Poly[1,3-bis(p-carboxyphenoxy)-propane anhydride]
9. The James Ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer
10. Polyanhydrides. I. Preparation of high molecular weight polyanhydrides
11. A simple model for the prediction of blood-brain partitioning
12. Paclitaxel disposition in plasma and central nervous systems of humans and rats with brain tumors
13. Modeling monomer release from bioerodible polymers
14. Assumptions in the radiotherapy of glioblastoma
15. Efficient inhibition of in vivo human malignant glioma growth and angiogenesis by interferon-beta treatment at early stage of tumor development
16. Inhibition of human malignant glioma growth in vivo by human recombinant plasminogen kringles 1-3
17. Chemotherapy for malignant gliomas
18. Chemotherapy of malignant gliomas
19. Cancer surveillance series: Brain and other central nervous system cancers: Recent trends in incidence and mortality
20. Synthesis of polyanhydrides: Melt-polycondensation, dehydrochlorination, and dehydrative coupling
21. The antitumor agent, 1,3-bis(2-chloroethy)-1-nitrosourea
22. Noninvasive monitoring of pH-gradients and free radical distributions in polyanhydrides by spectral-spatial-EPRI
23. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma. A pilot study
24. Pharmacokinetics of 11C-labelled BCNU and SarCNU in gliomas studied by PET
25. Phase I study of escalating doses of interstitial BCNU administered via wafer in patients with recurrent malignant glioma (mg)
26. Blocking of glioma proliferation in vitro and in vivo and potentiating the effects of BCNU and cisplatin: UCN-01, a selective protein kinase C inhibitor
27. Mikroskopische Technik
28. Phase II study of combination taxol and estramustine phosphate in the treatment of recurrent glioblastoma multiforme
29. Chemotherapy and immunotherapy of malignant glioma: Molecular mechanisms and clinical perspectives
30. Morphological studies on the effect of taxol on cultured human prostatic cancer cells
31. In vitro cellular characteristics and survival responses of human astrocytoma clones to chloroethyl nitrosoureas and dianhydrogalactitol
32. Experimental evaluation of potential anticancer agents: XIII. On the criteria and kinetics associated with "curability" of experimental leukemia
33. New delivery systems for brain tumor therapy
34. Five-year breeding data, immunology, and tumor take rates of an NMRI nude mouse colony
35. Interstitial chemotherapy of the 9L gliosarcoma: Controlled release polymers for drug delivery in the brain
36. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: A randomized double-blind study
37. Programmable biodegradable implants
38. Interstitial taxol delivered from a biodegradable polymer implant against experimental malignant glioma
39. Intratumoral chemotherapy